Clinical trial reportGynecologic oncologyPublished
Efficacy and safety of dostarlimab in combination with chemotherapy in patients with dMMR/MSI-H primary advanced or recurrent endometrial cancer in a phase 3, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)
Regional connection
Verified Author affiliations on the Europe PMC record name GSK, Jefferson Health, Sidney Kimmel Medical College, Thomas Jefferson University. Affiliation source
- County
- Montgomery County
Publication record
- Type
- Clinical trial report
- Venue
- Gynecologic oncology
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Endometrial Neoplasms; Neoplasm Recurrence, Local; Paclitaxel; Carboplatin; Antineoplastic Combined Chemotherapy Protocols; Double-Blind Method; Adult; Aged; Middle Aged; Female; Antibodies, Monoclonal, Humanized
- PubMed ID
- 39531903
- Added to directory
- Source checked